健保藥品的HTA評估報告
- 241 癌必定膜衣錠 20 毫克、40 毫克及60 毫克 (Cabometyx film-coated tablet 20 mg、40 mg、60 mg)
- 242 沛斯博凍晶注射劑 1 毫克 (BESPONSA 1 mg Powder for Concentrate for Solution for Infusion)
- 243 Kisqali 200mg Film-Coated Tablets
- 244 瑪威克錠 10 毫克(MAVENCLAD Tablets 10mg)
- 245 Venclexta Film-Coated Tablets
- 246 Imbruvica Capsules
- 247 Soliqua solution for injection
- 248 可帝敏持續性釋放錠 9 毫克(Cortiment MMX 9 mg prolonged release tablets)
- 249 Tresiba FlexTouch (Insulin Degludc Injection)
- 250 佳腎康錠Jinarc(15mg、30mg、45mg、60mg、90mg)